Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

ARNi: A Novel Approach to Counteract Cardiovascular Diseases.

Volpe M, Rubattu S, Battistoni A.

Int J Mol Sci. 2019 Apr 28;20(9). pii: E2092. doi: 10.3390/ijms20092092. Review.

2.

Hypertension in the elderly: which are the blood pressure threshold values?

Volpe M, Battistoni A, Rubattu S, Tocci G.

Eur Heart J Suppl. 2019 Mar;21(Suppl B):B105-B106. doi: 10.1093/eurheartj/suz023. Epub 2019 Mar 29. No abstract available.

3.

Molecular and clinical implications of natriuretic peptides in aortic valve stenosis.

Gallo G, Presta V, Volpe M, Rubattu S.

J Mol Cell Cardiol. 2019 Apr;129:266-271. doi: 10.1016/j.yjmcc.2019.03.011. Epub 2019 Mar 14. Review.

PMID:
30878394
4.

Mitochondrial complex I deficiency and cardiovascular diseases: current evidence and future directions.

Forte M, Palmerio S, Bianchi F, Volpe M, Rubattu S.

J Mol Med (Berl). 2019 May;97(5):579-591. doi: 10.1007/s00109-019-01771-3. Epub 2019 Mar 12. Review.

PMID:
30863992
5.

The reduction of NDUFC2 expression is associated with mitochondrial impairment in circulating mononuclear cells of patients with acute coronary syndrome.

Raffa S, Chin XLD, Stanzione R, Forte M, Bianchi F, Cotugno M, Marchitti S, Micaloni A, Gallo G, Schirone L, Tocci G, Violini R, Torrisi MR, Volpe M, Rubattu S.

Int J Cardiol. 2019 Jul 1;286:127-133. doi: 10.1016/j.ijcard.2019.02.027. Epub 2019 Feb 14.

PMID:
30808603
6.

Molecular Implications of Natriuretic Peptides in the Protection from Hypertension and Target Organ Damage Development.

Rubattu S, Forte M, Marchitti S, Volpe M.

Int J Mol Sci. 2019 Feb 13;20(4). pii: E798. doi: 10.3390/ijms20040798. Review.

7.

Natriuretic peptides in heart failure: Current achievements and future perspectives.

Volpe M, Battistoni A, Rubattu S.

Int J Cardiol. 2019 Apr 15;281:186-189. doi: 10.1016/j.ijcard.2018.04.045. Epub 2018 Dec 10. Review.

PMID:
30545616
8.

Chronic heart failure is characterized by altered mitochondrial function and structure in circulating leucocytes.

Coluccia R, Raffa S, Ranieri D, Micaloni A, Valente S, Salerno G, Scrofani C, Testa M, Gallo G, Pagannone E, Torrisi MR, Volpe M, Rubattu S.

Oncotarget. 2018 Oct 12;9(80):35028-35040. doi: 10.18632/oncotarget.26164. eCollection 2018 Oct 12.

9.

Dickkopf-3 Causes Neuroprotection by Inducing Vascular Endothelial Growth Factor.

Busceti CL, Di Menna L, Bianchi F, Mastroiacovo F, Di Pietro P, Traficante A, Bozza G, Niehrs C, Battaglia G, Bruno V, Fornai F, Volpe M, Rubattu S, Nicoletti F.

Front Cell Neurosci. 2018 Sep 11;12:292. doi: 10.3389/fncel.2018.00292. eCollection 2018.

10.

Executive Summary of the 2018 Joint Consensus Document on Cardiovascular Disease Prevention in Italy.

Volpe M, Battistoni A, Gallo G, Rubattu S, Tocci G; Writing Committee; Scientific Societies.

High Blood Press Cardiovasc Prev. 2018 Sep;25(3):327-341. doi: 10.1007/s40292-018-0278-8. Epub 2018 Sep 20. Review.

PMID:
30232768
11.

Cellular and subcellular localization of uncoupling protein 2 in the human kidney.

Nigro M, De Sanctis C, Formisano P, Stanzione R, Forte M, Capasso G, Gigliotti G, Rubattu S, Viggiano D.

J Mol Histol. 2018 Aug;49(4):437-445. doi: 10.1007/s10735-018-9782-3. Epub 2018 Jun 23.

PMID:
29936692
12.

Effects of dual angiotensin type 1 receptor/neprilysin inhibition vs. angiotensin type 1 receptor inhibition on target organ injury in the stroke-prone spontaneously hypertensive rat.

Rubattu S, Cotugno M, Forte M, Stanzione R, Bianchi F, Madonna M, Marchitti S, Volpe M.

J Hypertens. 2018 Sep;36(9):1902-1914. doi: 10.1097/HJH.0000000000001762.

PMID:
29916993
13.

Role of oxidative stress in the process of vascular remodeling following coronary revascularization.

Gallo G, Pierelli G, Forte M, Coluccia R, Volpe M, Rubattu S.

Int J Cardiol. 2018 Oct 1;268:27-33. doi: 10.1016/j.ijcard.2018.05.046. Epub 2018 May 19. Review.

PMID:
29803340
14.

Trehalose-Induced Activation of Autophagy Improves Cardiac Remodeling After Myocardial Infarction.

Sciarretta S, Yee D, Nagarajan N, Bianchi F, Saito T, Valenti V, Tong M, Del Re DP, Vecchione C, Schirone L, Forte M, Rubattu S, Shirakabe A, Boppana VS, Volpe M, Frati G, Zhai P, Sadoshima J.

J Am Coll Cardiol. 2018 May 8;71(18):1999-2010. doi: 10.1016/j.jacc.2018.02.066.

15.

[Consensus document and recommendations for the prevention of cardiovascular disease in Italy - 2018].

Volpe M, Tocci G, Accettura D, Battistoni A, Bellone S, Bellotti P, Bertolotti M, Borghi C, Casasco M, Consoli A, Coppini R, Corsini A, Costanzo G, Desideri G, Ferri C, Galanti G, Giada F, Icardi G, Lombardi N, Modena MG, Modesti PA, Monti G, Mugelli A, Orsi A, Parati G, Pedretti RF, Perseghin G, Pirro M, Ricotti R, Rizzoni D, Rotella C, Rubattu S, Salvetti G, Sarto P, Tassinari F, Trimarco B, de Kreutzenberg SV, Volpe R.

G Ital Cardiol (Rome). 2018 Feb;19(2 Suppl 1):1S-95S. doi: 10.1714/2874.28988. Italian.

PMID:
29531376
16.

The T2238C Human Atrial Natriuretic Peptide Molecular Variant and the Risk of Cardiovascular Diseases.

Rubattu S, Sciarretta S, Marchitti S, Bianchi F, Forte M, Volpe M.

Int J Mol Sci. 2018 Feb 11;19(2). pii: E540. doi: 10.3390/ijms19020540. Review.

17.

T2238C Atrial Natriuretic Peptide Gene Variant and the Response to Antiplatelet Therapy in Stable Ischemic Heart Disease Patients.

Strisciuglio T, Barbato E, De Biase C, Di Gioia G, Cotugno M, Stanzione R, Trimarco B, Sciarretta S, Volpe M, Wijns W, Delrue L, Rubattu S.

J Cardiovasc Transl Res. 2018 Feb;11(1):36-41. doi: 10.1007/s12265-017-9774-9. Epub 2017 Dec 5.

PMID:
29209941
18.

Uncoupling Protein 2: A Key Player and a Potential Therapeutic Target in Vascular Diseases.

Pierelli G, Stanzione R, Forte M, Migliarino S, Perelli M, Volpe M, Rubattu S.

Oxid Med Cell Longev. 2017;2017:7348372. doi: 10.1155/2017/7348372. Epub 2017 Oct 15. Review.

19.

In vitro characterization of mitochondrial function and structure in rat and human cells with a deficiency of the NADH: ubiquinone oxidoreductase Ndufc2 subunit.

Raffa S, Scrofani C, Valente S, Micaloni A, Forte M, Bianchi F, Coluccia R, Geurts AM, Sciarretta S, Volpe M, Torrisi MR, Rubattu S.

Hum Mol Genet. 2017 Dec 1;26(23):4541-4555. doi: 10.1093/hmg/ddx333.

20.

A Decrease of Brain MicroRNA-122 Level Is an Early Marker of Cerebrovascular Disease in the Stroke-Prone Spontaneously Hypertensive Rat.

Stanzione R, Bianchi F, Cotugno M, Marchitti S, Forte M, Busceti C, Ryskalin L, Fornai F, Volpe M, Rubattu S.

Oxid Med Cell Longev. 2017;2017:1206420. doi: 10.1155/2017/1206420. Epub 2017 Jun 18.

21.

Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.

Rubattu S, Stanzione R, Bianchi F, Cotugno M, Forte M, Della Ragione F, Fioriniello S, D'Esposito M, Marchitti S, Madonna M, Baima S, Morelli G, Sciarretta S, Sironi L, Gelosa P, Volpe M.

Cell Death Dis. 2017 Jun 22;8(6):e2891. doi: 10.1038/cddis.2017.278.

22.

C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP.

Carnevale R, Pignatelli P, Frati G, Nocella C, Stanzione R, Pastori D, Marchitti S, Valenti V, Santulli M, Barbato E, Strisciuglio T, Schirone L, Vecchione C, Violi F, Volpe M, Rubattu S, Sciarretta S.

Sci Rep. 2017 Jun 19;7(1):3797. doi: 10.1038/s41598-017-03679-9.

23.

A differential expression of uncoupling protein-2 associates with renal damage in stroke-resistant spontaneously hypertensive rat/stroke-prone spontaneously hypertensive rat-derived stroke congenic lines.

Rubattu S, Cotugno M, Bianchi F, Sironi L, Gelosa P, Stanzione R, Forte M, De Sanctis C, Madonna M, Marchitti S, Pignieri A, Sciarretta S, Volpe M.

J Hypertens. 2017 Sep;35(9):1857-1871. doi: 10.1097/HJH.0000000000001374.

PMID:
28399045
24.
25.

Dickkopf-3 Upregulates VEGF in Cultured Human Endothelial Cells by Activating Activin Receptor-Like Kinase 1 (ALK1) Pathway.

Busceti CL, Marchitti S, Bianchi F, Di Pietro P, Riozzi B, Stanzione R, Cannella M, Battaglia G, Bruno V, Volpe M, Fornai F, Nicoletti F, Rubattu S.

Front Pharmacol. 2017 Mar 14;8:111. doi: 10.3389/fphar.2017.00111. eCollection 2017.

26.

Rac1 Pharmacological Inhibition Rescues Human Endothelial Dysfunction.

Carrizzo A, Vecchione C, Damato A, di Nonno F, Ambrosio M, Pompeo F, Cappello E, Capocci L, Peruzzi M, Valenti V, Biondi-Zoccai G, Marullo AG, Palmerio S, Carnevale R, Spinelli CC, Puca AA, Rubattu S, Volpe M, Sadoshima J, Frati G, Sciarretta S.

J Am Heart Assoc. 2017 Feb 28;6(3). pii: e004746. doi: 10.1161/JAHA.116.004746.

27.

Role of NOX2 in mediating doxorubicin-induced senescence in human endothelial progenitor cells.

De Falco E, Carnevale R, Pagano F, Chimenti I, Fianchini L, Bordin A, Siciliano C, Monticolo R, Equitani F, Carrizzo A, Peruzzi M, Vecchione C, Rubattu S, Sciarretta S, Frati G.

Mech Ageing Dev. 2016 Oct;159:37-43. doi: 10.1016/j.mad.2016.05.004. Epub 2016 May 12.

PMID:
27181082
28.

Natriuretic peptides and integrated risk assessment for cardiovascular disease: an individual-participant-data meta-analysis.

Natriuretic Peptides Studies Collaboration, Willeit P, Kaptoge S, Welsh P, Butterworth AS, Chowdhury R, Spackman SA, Pennells L, Gao P, Burgess S, Freitag DF, Sweeting M, Wood AM, Cook NR, Judd S, Trompet S, Nambi V, Olsen MH, Everett BM, Kee F, Ärnlöv J, Salomaa V, Levy D, Kauhanen J, Laukkanen JA, Kavousi M, Ninomiya T, Casas JP, Daniels LB, Lind L, Kistorp CN, Rosenberg J, Mueller T, Rubattu S, Panagiotakos DB, Franco OH, de Lemos JA, Luchner A, Kizer JR, Kiechl S, Salonen JT, Goya Wannamethee S, de Boer RA, Nordestgaard BG, Andersson J, Jørgensen T, Melander O, Ballantyne ChM, DeFilippi Ch, Ridker PM, Cushman M, Rosamond WD, Thompson SG, Gudnason V, Sattar N, Danesh J, Di Angelantonio E.

Lancet Diabetes Endocrinol. 2016 Oct;4(10):840-9. doi: 10.1016/S2213-8587(16)30196-6. Epub 2016 Sep 3.

29.

Mitochondrial Dysfunction Contributes to Hypertensive Target Organ Damage: Lessons from an Animal Model of Human Disease.

Rubattu S, Stanzione R, Volpe M.

Oxid Med Cell Longev. 2016;2016:1067801. doi: 10.1155/2016/1067801. Epub 2016 Aug 9. Review.

30.

A Next-Generation Sequencing Approach to Identify Gene Mutations in Early- and Late-Onset Hypertrophic Cardiomyopathy Patients of an Italian Cohort.

Rubattu S, Bozzao C, Pennacchini E, Pagannone E, Musumeci BM, Piane M, Germani A, Savio C, Francia P, Volpe M, Autore C, Chessa L.

Int J Mol Sci. 2016 Jul 30;17(8). pii: E1239. doi: 10.3390/ijms17081239.

31.

NT-proANP and NT-proBNP circulating levels as predictors of cardiovascular outcome following coronary stent implantation.

Niccoli G, Conte M, Marchitti S, Montone RA, Fracassi F, Grippo R, Roberto M, Burzotta F, Trani C, Leone AM, Bianchi F, Di Castro S, Volpe M, Crea F, Rubattu S.

Cardiovasc Revasc Med. 2016 Apr-May;17(3):162-8. doi: 10.1016/j.carrev.2016.02.012. Epub 2016 Feb 27.

PMID:
26987266
32.

Ndufc2 Gene Inhibition Is Associated With Mitochondrial Dysfunction and Increased Stroke Susceptibility in an Animal Model of Complex Human Disease.

Rubattu S, Di Castro S, Schulz H, Geurts AM, Cotugno M, Bianchi F, Maatz H, Hummel O, Falak S, Stanzione R, Marchitti S, Scarpino S, Giusti B, Kura A, Gensini GF, Peyvandi F, Mannucci PM, Rasura M, Sciarretta S, Dwinell MR, Hubner N, Volpe M.

J Am Heart Assoc. 2016 Feb 17;5(2). pii: e002701. doi: 10.1161/JAHA.115.002701.

33.
34.

New therapies for arterial hypertension.

Pagliaro B, Santolamazza C, Rubattu S, Volpe M.

Panminerva Med. 2016 Mar;58(1):34-47. Epub 2016 Jan 5. Review.

PMID:
26730462
35.

C2238/αANP modulates apolipoprotein E through Egr-1/miR199a in vascular smooth muscle cells in vitro.

Stanzione R, Sciarretta S, Marchitti S, Bianchi F, Di Castro S, Scarpino S, Cotugno M, Frati G, Volpe M, Rubattu S.

Cell Death Dis. 2015 Dec 31;6:e2033. doi: 10.1038/cddis.2015.370.

36.

Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art.

Pagliaro B, Santolamazza C, Simonelli F, Rubattu S.

Biomed Res Int. 2015;2015:918069. doi: 10.1155/2015/918069. Epub 2015 Oct 4. Review.

37.

Angiotensin II Receptor Blocker Neprilysin Inhibitor (ARNI): New Avenues in Cardiovascular Therapy.

Volpe M, Tocci G, Battistoni A, Rubattu S.

High Blood Press Cardiovasc Prev. 2015 Sep;22(3):241-6. doi: 10.1007/s40292-015-0112-5. Epub 2015 Jun 23. Review.

PMID:
26100410
38.

Differential modulation of AMPK/PPARα/UCP2 axis in relation to hypertension and aging in the brain, kidneys and heart of two closely related spontaneously hypertensive rat strains.

Rubattu S, Bianchi F, Busceti CL, Cotugno M, Stanzione R, Marchitti S, Di Castro S, Madonna M, Nicoletti F, Volpe M.

Oncotarget. 2015 Aug 7;6(22):18800-18.

39.

Protective effects of Brassica oleracea sprouts extract toward renal damage in high-salt-fed SHRSP: role of AMPK/PPARα/UCP2 axis.

Rubattu S, Di Castro S, Cotugno M, Bianchi F, Mattioli R, Baima S, Stanzione R, Madonna M, Bozzao C, Marchitti S, Gelosa P, Sironi L, Pignieri A, Maldini M, Giusti AM, Nardini M, Morelli G, Costantino P, Volpe M.

J Hypertens. 2015 Jul;33(7):1465-79. doi: 10.1097/HJH.0000000000000562.

PMID:
25807219
40.

RyR2 Common Gene Variant G1886S and the Risk of Ventricular Arrhythmias in ICD Patients with Heart Failure.

Francia P, Adduci C, Semprini L, Stanzione R, Serdoz A, Caprinozzi M, Santini D, Cotugno M, Palano F, Musumeci MB, Rubattu S, Volpe M.

J Cardiovasc Electrophysiol. 2015 Jun;26(6):656-61. doi: 10.1111/jce.12658. Epub 2015 May 1.

PMID:
25773045
41.

Hypovitaminosis D and organ damage in patients with arterial hypertension: a multicenter double blind randomised controlled trial of cholecalciferol supplementation (HYPODD) : study design, clinical procedures and treatment protocol.

Rendina D, Ippolito R, D'Elia L, Giacchetti G, Lonati C, Gianfrancesco F, Fallo F, Rebellato A, Ruggiero C, Rubattu S, Volpe M, Gennari L, Merlotti D, Isaia GC, D'Amelio P, Spertino E, Fabris B, Sechi LA, Catena C, Maresca AM, Gessi V, Dalbeni A, Strazzullo P.

High Blood Press Cardiovasc Prev. 2015 Jun;22(2):135-42. doi: 10.1007/s40292-015-0080-9. Epub 2015 Mar 14.

42.

Pathogenesis of target organ damage in hypertension: role of mitochondrial oxidative stress.

Rubattu S, Pagliaro B, Pierelli G, Santolamazza C, Castro SD, Mennuni S, Volpe M.

Int J Mol Sci. 2014 Dec 31;16(1):823-39. doi: 10.3390/ijms16010823. Review.

43.

The C2238/αANP variant is a negative modulator of both viability and function of coronary artery smooth muscle cells.

Rubattu S, Marchitti S, Bianchi F, Di Castro S, Stanzione R, Cotugno M, Bozzao C, Sciarretta S, Volpe M.

PLoS One. 2014 Nov 17;9(11):e113108. doi: 10.1371/journal.pone.0113108. eCollection 2014.

44.

High natriuretic peptide levels and low DBP: companion markers of cardiovascular risk?

Rubattu S, Volpe M.

J Hypertens. 2014 Nov;32(11):2142-3. doi: 10.1097/HJH.0000000000000365. No abstract available.

PMID:
25271913
45.

T2238C ANP gene variant and risk of recurrent acute coronary syndromes in an Italian cohort of ischemic heart disease patients.

Rubattu S, De Giusti M, Farcomeni A, Abbolito S, Comito F, Cangianiello S, Greco ES, Dito E, Pagliaro B, Cotugno M, Stanzione R, Marchitti S, Bianchi F, Di Castro S, Battistoni A, Burocchi S, Caprinozzi M, Pierelli G, Sciarretta S, Volpe M.

J Cardiovasc Med (Hagerstown). 2016 Aug;17(8):601-7. doi: 10.2459/JCM.0000000000000195.

PMID:
25252038
46.

An easy and reproducible parameter for the assessment of the pressure gradient in patients with aortic stenosis disease: A magnetic resonance study.

Valenti V, Sciarretta S, Levin M, Shubayev L, Edelstein S, Zia MI, Rubattu S, Volpe M, Uretsky S, Wolff SD.

J Cardiol. 2015 May;65(5):369-76. doi: 10.1016/j.jjcc.2014.07.015. Epub 2014 Aug 22.

47.

New insights into the role of mitochondrial dynamics and autophagy during oxidative stress and aging in the heart.

Ikeda Y, Sciarretta S, Nagarajan N, Rubattu S, Volpe M, Frati G, Sadoshima J.

Oxid Med Cell Longev. 2014;2014:210934. doi: 10.1155/2014/210934. Epub 2014 Jul 15. Review.

48.

Atrial natriuretic peptide gene variants and circulating levels: implications in cardiovascular diseases.

Rubattu S, Sciarretta S, Volpe M.

Clin Sci (Lond). 2014 Jul;127(1):1-13. doi: 10.1042/CS20130427. Review.

PMID:
24611929
49.

Polypharmacy in heart failure patients.

Mastromarino V, Casenghi M, Testa M, Gabriele E, Coluccia R, Rubattu S, Volpe M.

Curr Heart Fail Rep. 2014 Jun;11(2):212-9. doi: 10.1007/s11897-014-0186-8. Review.

PMID:
24493574
50.

Pathogenesis of chronic cardiorenal syndrome: is there a role for oxidative stress?

Rubattu S, Mennuni S, Testa M, Mennuni M, Pierelli G, Pagliaro B, Gabriele E, Coluccia R, Autore C, Volpe M.

Int J Mol Sci. 2013 Nov 20;14(11):23011-32. doi: 10.3390/ijms141123011. Review.

Supplemental Content

Loading ...
Support Center